Literature DB >> 14667692

Mechanical heart valves: 50 years of evolution.

Vincent L Gott1, Diane E Alejo, Duke E Cameron.   

Abstract

The past 50 years have witnessed remarkable progress in the development of safe, hemodynamically favorable mechanical heart valves. Starr-Edwards aortic and mitral ball valves introduced in the mid-1960s, continue to be used successfully worldwide. More than 100,000 Omniscience and Omnicarbon tilting-disc valves have been implanted since 1978 with essentially no mechanical failure; similar results have been obtained with more than 300,000 Hall-Kaster and Medtronic-Hall tilting-disc valves over the past 25 years. Pyrolytic carbon, originally used to encapsulate nuclear fuel rods, has been adapted for the fabrication of discs, leaflets and the housings for more than 2 million mechanical valves. The St. Jude bileaflet valves, totally fabricated from pyrolytic carbon, have remained virtually unchanged in design since their introduction in 1977. More than 1.3 million of these valves have been implanted worldwide with virtually no reported failures of the carbon leaflets or housings. Similarly, pyrolytic carbon bileaflet Carbomedics valves have been implanted in more than 500,000 patients since 1986. Now, 50 years after Dr Gibbon's seminal achievement, patients with debilitating valve disease can have elective valve replacement (mechanical or tissue) with an operative mortality approaching 1% to 2% and a low lifetime complication rate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667692     DOI: 10.1016/j.athoracsur.2003.09.002

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  32 in total

1.  Translating clinical research to the bedside: the Minnesota model.

Authors:  Jennifer L Hall; Leslie W Miller; Soon J Park
Journal:  J Cardiovasc Transl Res       Date:  2008-10-21       Impact factor: 4.132

2.  A parametric study on mathematical formulation and geometrical construction of a stentless aortic heart valve.

Authors:  Esfandyar Kouhi; Yosry S Morsi
Journal:  J Artif Organs       Date:  2013-06-30       Impact factor: 1.731

3.  Tunable Elastomers with an Antithrombotic Component for Cardiovascular Applications.

Authors:  Alexander M Stahl; Yunzhi Peter Yang
Journal:  Adv Healthc Mater       Date:  2018-05-31       Impact factor: 9.933

Review 4.  Surgical Treatment of Valvular Heart Disease: Overview of Mechanical and Tissue Prostheses, Advantages, Disadvantages, and Implications for Clinical Use.

Authors:  Amy G Fiedler; George Tolis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-05

5.  Early results of the Sorin® Perceval S sutureless valve: systematic review and meta-analysis.

Authors:  Karan Sian; Sheila Li; Daneish Selvakumar; Ross Mejia
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

6.  Quadruple valve replacement for rheumatic valvular disease. Excellent durability for 20 years.

Authors:  A B Budak; K Korkmaz; H S Gedik; S B Genç; A Ü Yener; İ Alur; K Çağlı
Journal:  Herz       Date:  2014-04-11       Impact factor: 1.443

Review 7.  Minimally invasive valve surgery.

Authors:  Nicolas H Pope; Gorav Ailawadi
Journal:  J Cardiovasc Transl Res       Date:  2014-05-06       Impact factor: 4.132

Review 8.  Narrative review of the contemporary surgical treatment of unicuspid aortic valve disease.

Authors:  Maria von Stumm; Tatjana Sequeira-Gross; Johannes Petersen; Shiho Naito; Lisa Müller; Christoph Sinning; Evaldas Girdauskas
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 9.  Polymeric trileaflet prosthetic heart valves: evolution and path to clinical reality.

Authors:  Thomas E Claiborne; Marvin J Slepian; Syed Hossainy; Danny Bluestein
Journal:  Expert Rev Med Devices       Date:  2012-11       Impact factor: 3.166

10.  Premeditated reoperation after mitral valve replacement with a Starr-Edwards ball valve for young women who desire to bear a child: report of two cases.

Authors:  Ryota Asano; Kiyoharu Nakano; Kojiro Kodera; Noriyuki Murai; Akihito Sasaki; Masahiro Ikeda; Go Kataoka; Akiko Yamaguchi; Satoru Domoto; Yasuo Takeuchi
Journal:  Surg Today       Date:  2009-07-29       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.